Clinical Trial Update: Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial results for inhaled treprostinil sodium in pulmonary hypertension associated with idiopathic pulmonary fibrosis were posted in 2012. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Hypertension

Drugs mentioned

• Inhaled treprostinil (treprostinil sodium) (treprostinil)

Snippet

Sponsor: Lung Biotechnology PBC | Conditions: Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2012-05-10